SLC35G4

Across TCGA pan-cancer cohorts, SLC35G4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SLC35G4’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where SLC35G4 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC35G4 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA and BRCA are the cancer types where SLC35G4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC35G4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.047	<.001	4	view →
BRCA	All	II,III,IV	−0.006	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SLC35G4–THCA

Open the THCA breakdown →